[Pharmacodynamic aspects of ganglion blocking agents with tertiary ammonium function (antihistaminics, spasmolytics and phenothiazine derivatives) recently introduced as anesthetic adjuvants in clinical use].
D000759:Adjuvants, Anesthesia; D064751:Ammonium Compounds; D000758:Anesthesia; D018926:Anti-Allergic Agents; D005730:Ganglionic Blockers; D006634:Histamine H1 Antagonists; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics; D010640:Phenothiazines / Q000031:analogs & derivatives
D000759:Adjuvants, Anesthesia; D064751:Ammonium Compounds; D018926:Anti-Allergic Agents; D005730:Ganglionic Blockers; D006634:Histamine H1 Antagonists; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D010640:Phenothiazines; C031637:phenothiazine
ANESTHESIA; ANTIHISTAMINICS; MUSCLE RELAXANTS/therapeutic use; PHENOTHIAZINE/derivatives
Aspects pharmacodynamiques des ganglioplégiques à fonction ammonium tertiaire (antihistaminiques, spasmolytiques et derivés de la phénothiazine) récemment introduits en clinique comme adjuvant de l'anesthésie.